Selfdiagnostics Deutschland GmbH

Several pipettes above vessels provided for this purpose

Selfdiagnostics Deutschland GmbH

{subtitle}

Case Study

Rapid testing methods are becoming increasingly vital for the accurate identification and treatment of diseases, including epidemic prevention. Selfdiagnostics Deutschland GmbH is revolutionizing this field of diagnostics with its innovative approaches and technologies.

Founded in Leipzig in 2011, the R&D company develops and manufactures products which can detect a variety of different illnesses. Their team of scientists and engineers created a platform of single-use multiplex molecular diagnostic tests for a range of infections, including COVID-19.

single-use multiplex molecular diagnostic tests

Medical problem-solving at this highest level requires a unique blend of know-how, infrastructure and funding. Leipzig proved itself to be an ideal location in this regard, offering the company numerous benefits:

  • Situated at the center of Germany in the heart of Europe, making it a pivotal traffic and logistics hub (i.e. airport)
  • Site of the life science hub BioCity with its customized laboratory, office, manufacturing and warehouse spaces
  • Chance to collaborate with the best European universities, institutes and virology laboratories, e.g. the Fraunhofer Institute for Cell Therapy and Immunology
  • Access to potential investors and additional funding, e.g. with the Sächsische Aufbaubank

The company established its headquarters on Leipzig’s BioCity Campus, which enables innovative Start Ups like Selfdiagnostics to mature into successful Grow Ups with wide market penetration.

“Leipzig was our first choice because this is where we found great people creating great things together!”

says company founder Marko Lehes. “We know we can reach our goals here: To make our diagnostics fast, easy, scalable – and accessible to as many people as possible.”

Small as a credit card, the PCR testing platform combines the ease-of-use of a rapid test with the accuracy of a PCR test – with a fast turnaround. The COVID-19 Multitest e.g. delivers a reliable result with near 100% sensitivity and specificity in 45 minutes.

Selfdiagnostics Deutschland GmbH

Selfdiagnostics is an Estonian-German R&D company which develops, manufactures and sells medical devices. Its product portfolio includes diagnostic tests, inhalers and blood pressure monitors. After successfully launching a rapid diagnostic test for sexually transmitted diseases, the company is now focusing on developing RNA diagnostic products for SARS-CoV-2 and other respiratory viruses. Find out more at: selfdiagnostics.eu

News

More Case Studies

Saventic Health

Several pipettes above vessels provided for this purpose

diagnostics

Several pipettes above vessels provided for this purpose

Diagnosing rare diseases so patients can receive timely treatment is a major challenge in healthcare. Saventic Health is transforming medical diagnostics by using artificial intelligence (AI) to identify rare diseases, reduce diagnosis times and expedite treatment.

Intu Diagnostics

Several pipettes above vessels provided for this purpose

diagnostics

Several pipettes above vessels provided for this purpose

Testing for infectious diseases can be a slow, complex and resource-intensive process. Intu Diagnostics is transforming the diagnostic landscape with fast, affordable and easy-to-use diagnostic solutions which anyone around the world can use to test themselves.

Back to top